Interpace Biosciences, Inc. (IDXG) Financials
IDXG Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 14.3 million | 76.9 million |
2023-06-30 | 15.9 million | 78.1 million |
2023-03-31 | 15.9 million | 78.4 million |
2022-12-31 | 16.0 million | 79.1 million |
IDXG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | ? | ? |
2023-06-30 | 300000 | 157000 |
2023-03-31 | 1.1 million | 192000 |
2022-12-31 | -472000 | 125000 |
IDXG Net Income
No data available :(
IDXG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | - | - | 2.0 million |
2023-06-30 | - | - | 2.1 million |
2023-03-31 | - | - | 2.3 million |
2022-12-31 | - | - | 2.4 million |
IDXG Shares Outstanding
IDXG Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | - | - | - |
2023-06-30 | 111000 | 186000 | 5.5 million | - |
2023-03-31 | 111000 | 149000 | 4.8 million | - |
2022-12-31 | 7.6 million | 77000 | 4.5 million | - |
IDXG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | 11.0 million | 4.2 million |
2023-03-31 | 9.8 million | 3.8 million |
2022-12-31 | 8.3 million | 3.3 million |
IDXG
Price: $1.41
52 week price:
Earnings Per Share: -0.43 USD
P/E Ratio: -2.17
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1193
Ebitda: -2.5 millionMarket Capitalization: 6.3 million